Slingluff, C. L., Fling, S., Mauldin, I. S., Ernstoff, M. S., Hanks, B. A., Delman, K. A., … Cheever, M. A. (2018). Pilot trial of an Indoleamine 2,3-dioxygenase-1 (IDO1) inhibitor plus a multipeptide melanoma vaccine in patients with advanced melanoma. In Journal of Clinical Oncology (Vol. 36, pp. 3033–3033). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2018.36.15_suppl.3033

Slingluff, Craig L., Steven Fling, Ileana S. Mauldin, Marc S. Ernstoff, Brent Allen Hanks, Keith A. Delman, David H. Lawson, Brian Gastman, Judith C. Kaiser, and Martin A. Cheever. “Pilot trial of an Indoleamine 2,3-dioxygenase-1 (IDO1) inhibitor plus a multipeptide melanoma vaccine in patients with advanced melanoma.” In Journal of Clinical Oncology, 36:3033–3033. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.3033.

Slingluff CL, Fling S, Mauldin IS, Ernstoff MS, Hanks BA, Delman KA, et al. Pilot trial of an Indoleamine 2,3-dioxygenase-1 (IDO1) inhibitor plus a multipeptide melanoma vaccine in patients with advanced melanoma. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. 3033–3033.

Slingluff, Craig L., et al. “Pilot trial of an Indoleamine 2,3-dioxygenase-1 (IDO1) inhibitor plus a multipeptide melanoma vaccine in patients with advanced melanoma.” Journal of Clinical Oncology, vol. 36, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2018, pp. 3033–3033. Crossref, doi:10.1200/jco.2018.36.15_suppl.3033.

Slingluff CL, Fling S, Mauldin IS, Ernstoff MS, Hanks BA, Delman KA, Lawson DH, Gastman B, Kaiser JC, Cheever MA. Pilot trial of an Indoleamine 2,3-dioxygenase-1 (IDO1) inhibitor plus a multipeptide melanoma vaccine in patients with advanced melanoma. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. 3033–3033.